Drug Industry Document Archive (DIDA) Adds 15 More Pharma-Related Documents To Collection In November 2009
on Nov 20, 2009 in Pharma Industry Trends DIDA Drug-Industry-Document-Archive Pharma UCSF University-California-San-Francisco This Archive Contains Some "Secret" Documents Only Made Public In The Course Of Lawsuits Filed Against Pharmaceutical Companies (Posted by Tom Lamb at DrugInjuryWatch.com) Created and maintained by the University of California at San Franci...

Consumers Union’s Safe Patient Project Forum Webcast: “To Err Is Human, To Delay Is Deadly”
on Nov 17, 2009 in Medication Errors Patient Resources Consumers-Union drug-safety hospital-acquired-infections medical-errors medical-harm medication-mistakes physician-accountability Safe-Patient-Project Marks 10th Anniversary Of IOM Study On Medical Errors And Raises Concerns About Lack Of Progress (Posted by Tom Lamb at DrugInjuryWatch.com) The Consumers Union’s Safe Patient Project (formerly Stop Hospital Infections) is holding a forum, “To Er...

Anemia Drugs Procrit And Aranesp May Increase Twofold The Risk Of Potentially Fatal Blood Clots
on Nov 11, 2009 in Drug Safety Alerts Side Effect: Cardiovascular (heart attack, stroke, heart valve damage, PE, DVT) Aranesp blood-clots drug-injury ESAs Procrit side-effects strokes Results From Large Long-Term Study Show Association Between These Erythropoiesis-Stimulating Agents And Venous Thromboembolism(Posted by Tom Lamb at DrugInjuryWatch.com) In late October 2009 we learned that the results from the Trial to Reduce Cardio...

Aranesp Associated With Increased Risk For Stroke In Patients With Diabetes And Chronic Kidney Disease
on Nov 6, 2009 in Drug Safety Alerts Side Effect: Cardiovascular (heart attack, stroke, heart valve damage, PE, DVT) Amgen Aranesp drug-injury NEJM placebo stroke TREAT Study Revealed, Also, That This Amgen Anemia Drug Was No Better Than Placebo In Reducing Deaths Or Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) The anemia drug Aranesp (darbepoetin alfa) might cause an increased risk for...

Diabetes Drug Byetta Linked To Kidney Problems And Cases Of Renal Failure
on Nov 3, 2009 in "Dear Doctor" Letters Drug Safety Alerts FDA Drug Safety Oversight Side Effect: Kidney Injury (acute renal failure, kidney transplant) Amylin-Pharmaceuticals Byetta Dear-Doctor Eli-Lilly exenatide FDA kidney-function label-change renal-failure October 2009 Byetta Label Change Follows Earlier Alert From U.K. About Kidney-Related Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) In March 2009 the Drug Safety Update Newsletter alerted us about reports of kidney-related side effects ass...

FDA Should Make Drug Efficacy And Safety Information More Accessible To Patients
on Oct 27, 2009 in FDA Drug Safety Oversight Patient Resources Pharma Industry Trends Big-Pharma drug-safety FDA Lunesta NEJM Zometa Package Inserts Prepared By Drug Companies Which Exagerrate Benefits And Downplay Risks Need To Be Addressed (Posted by Tom Lamb at DrugInjuryWatch.com) In the October 21, 2009 edition of The New England Journal of Medicine (NEJM) there is a Perspect...

Yasmin And Yaz Birth Control Pills Are Under Scrutiny By Drug Regulators In Europe
on Oct 22, 2009 in Side Effect: Cardiovascular (heart attack, stroke, heart valve damage, PE, DVT) Bayer drug-injury drug-safety Germany lawsuits Switzerland United-States Yasmin Yaz Bayer Confirms To German Newspaper There Are 129 Yasmin / Yaz Lawsuits In U.S. As Of Mid-October 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) From an October 21, 2009 article, "Bayer under pressure as birth control pills linked to blood clot...

First Zometa-ONJ Personal Injury Lawsuit Against Novartis Goes To Jury This Week
on Oct 20, 2009 in Legal Case Updates Side Effect: Bone Disease (osteonecrosis, osteomyelitis) drug-injury Fosamax jaw-damage law lawsuit legal Montana Novartis ONJ Peggy-Stevens trial-verdict Zometa Montana Woman's Case Is First To Trial; More Than 500 Other Jaw Side Effect Cases Filed In Federal MDL And New Jersey Courts (Posted by Tom Lamb at DrugInjuryWatch.com) Let us set the stage, medically, by starting with an article, "Osteoporosis...

An Overview, Progress To Date, And Next Steps In FDA’s Sentinel Initiative
on Oct 15, 2009 in FDA Drug Safety Oversight drug-injury Drug-Safety-Oversight-Board FDA Sentinel-Initiative Presentation Made At September 17, 2009 FDA Drug Safety Oversight Board Meeting (Posted by Tom Lamb at DrugInjuryWatch.com) At the September 17, 2009 meeting of the FDA Drug Safety Oversight Board (DSB), members heard presentations and discussed four...

FDA’s Sentinel Initiative Project: An Overview, Progress To Date, And Next Steps
on Oct 15, 2009 in FDA Drug Safety Oversight drug-injury Drug-Safety-Oversight-Board FDA Sentinel-Initiative Presentation Made At September 17, 2009 FDA Drug Safety Oversight Board Meeting (Posted by Tom Lamb at DrugInjuryWatch.com) At the September 17, 2009 meeting of the FDA Drug Safety Oversight Board (DSB), members heard presentations and discussed four...